Osteoporosis International

Article	Citations
Dual-energy x-ray absorptiometry scanner mismatch in follow-up bone mineral density testing	638
Comment on “Rebound hypercalcemia post-denosumab cessation in metastatic breast cancer”: Waxing-Waning Serum Calcium following Denosumab use in a patient with Polyostotic Paget’s Disease of Bone	221
RE: “Race/ethnic differences in trabecular bone score in mid-life women: the Study of Women’s Health Across the Nation (SWAN)”	79
Comparison of the efficacy between sequential therapy with teriparatide and denosumab and denosumab monotherapy in suppressing fragility fracture risk	78
The effects of β-carotene on osteoporosis: a systematic review and meta-analysis of observational studies	74
Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	69
Incident peptic ulcers and concomitant treatment of direct oral anticoagulants and oral bisphosphonates—a real-world cohort study	68
Mineral-rich water consumption as a non-pharmacological intervention for early menopausal bone mineral density preservation and reduction of long-term fracture risk: comment on Billington et al. Osteo	53
A promising strategy for the diagnosis, treatment, and prevention of osteoporosis (EMS strategy)	52
The incidence of subsequent contralateral hip fracture and factors associated with increased risk: the IMPACT Contralateral Fracture Study	49
Trajectories of oral bisphosphonate use after hip fractures: a population-based cohort study	49
Impact of the guidance on fracture Liaison Services and the introduction of a new fee for secondary fracture prevention in Japan: Implementation of secondary fracture prevention during hospitalization	47
Correction to: Author response to the comments on our article Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture pat	41
One versus 2 years of alendronate following denosumab: the CARD extension	41
The clinical trial landscape of anti-RANKL agents for osteoporosis: current status and future directions	39
The association between blood cadmium levels and bone mineral density in U.S. adolescents aged 12–19 years	37
Scaffolds: a biomaterial engineering in targeted drug delivery for osteoporosis	37
Return on investment of fracture liaison services: a systematic review and analysis	36
RETRACTED ARTICLE: Evaluation of bone mineral density (BMD) and trabecular bone score (TBS) in pheochromocytoma and paraganglioma; a multi-centric case–control study from India	35
Epidemiology of pelvic and acetabular fractures in the USA from 2007 to 2014	35
Changes in spinal sagittal balance after a new osteoporotic vertebral compression fracture	33
Association between body mass index, bone bending strength, and BMD in young sedentary women	32
Follicle-stimulating hormone is associated with low bone mass in postmenopausal women	32
Author response to: Comment from Dongdong Cao, et al. on: Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nati	31
Artificial intelligence insights into osteoporosis: comment	31

Association between dental diseases and oral hygiene care and the risk of vertebral fracture: a nationwide cohort study	30
Evaluating the impact of COVID-19 on DXA waiting lists and osteoporosis prescription trends in England 2019–2023	30
Opportunistic measures of bone mineral density at multiple skeletal sites during whole-body CT in polytrauma patients	30
Clinical and demographic factors determining patient fracture risk decision point (FRDP): The improving risk communication in osteoporosis (RICO) project	29
Bisphosphonate drug holidays in osteoporosis according to fracture risk profile	28
Polymorphic variants of alkaline phosphatase gene correlate with clinical signs of adult hypophosphatasia?	27
Patients not taking a previously prescribed bone active medication now prescribed medication through Ontario FLS	27
Internal medicine inpatients’ prevalence of misdiagnosed severe osteoporosis	27
Alendronate preserves bone mineral density in adults with sickle cell disease and osteoporosis	27
An LRP6 mutation (Arg360His) associated with low bone mineral density but not cardiovascular events in a Caucasian family	27
A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis	26
Comparison of pharmacokinetics, pharmacodynamics, safety, and immunogenicity of teriparatide biosimilar with EU- and US-approved teriparatide reference products in healthy men and postmenopausal women	26
International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures	26
Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study	25
Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year	24
Atypical femoral fracture after denosumab for the treatment of osteoporosis in bisphosphonate naïve patients: two further cases	24
Romosozumab and antiresorptive treatment: the importance of treatment sequence	24
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESPRM-ESCEO-IOF Symposium Abstracts	24
Comparison of radiological and functional outcomes of conservative treatment with teriparatide and denosumab in thoracolumbar osteoporotic vertebral fracture	24
Cost-effectiveness analyses of denosumab for osteoporosis: a systematic review	23
Semi-automatic proximal humeral trabecular bone density assessment tool: technique application and clinical validation	23
Does exercise affect bone mineral density and content when added to a calorie-restricted diet? A systematic review and meta-analysis of controlled clinical trials	22
Correction to: Secular trends of incidence and hospitalization cost of hip fracture in Tangshan, China	22
Causal relationship between type 2 diabetes mellitus and bone mineral density: a Mendelian randomization study in an East Asian population	22
Correction to: Response to letter, re. “Comparison of fracture risk between type 1 and type 2 diabetes: a comprehensive real-world data”	22
Metformin treatment reduces the incidence of osteoporosis: a two-sample Mendelian randomized study	22
Fracture risk following bariatric surgery: a systematic review and meta-analysis	22
Opportunistic osteoporosis screening using chest CT with artificial intelligence	22
Correction: PTH1 receptor agonists for fracture risk: a systematic review and network meta-analysis	21
Author response to OSIN-D-23–00510, “Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients re	21
Twenty-four months of follow-up in women with rebound-associated vertebral fractures after discontinuation of denosumab: a single-centre case series	20
Comorbidity and risk of infection among patients with hip fracture: a Danish population-based cohort study	19
Imaging of pelvic ring fractures in older adults and its clinical implications-a systematic review	19
The importance of structural barriers of osteoporotic hip fracture in the elderly	19
Zoledronic acid–induced severe lymphopenia	19
Comment on: A novel sequential treatment approach between denosumab and romosozumab in patients with severe osteoporosis	18
Denosumab and clinical outcomes among men with osteoporosis: a retrospective cohort study	18
Exercise-induced hypercalcemia and vasopressin-mediated bone resorption	18
Predictive ability of novel volumetric and geometric indices derived from dual-energy X-ray absorptiometric images of the proximal femur for hip fracture compared with conventional areal bone mineral	18
Comment on: The association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	18
Insulin resistance, bone health, and fracture risk	18
The association of coffee consumption with the risk of osteoporosis and fractures: a systematic review and meta-analysis	18
Updated trabecular bone score accounting for the soft tissue thickness (TBSTT) demonstrated significantly improved bone microstructure with denosumab in the FREEDOM TBS post hoc analysis	18
In memoriam: Vladyslav Povoroznyuk	17
The association between lumbar paraspinal muscle functional cross-sectional area on MRI and regional volumetric bone mineral density measured by quantitative computed tomography	17
Short- and long-term prognostic factors associated with functional recovery in elderly patients with hip fracture: A systematic review	17
Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	17
Proposed bone health screening protocol to identify total knee arthroplasty patients for preoperative DXA	17
Correction to: Determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: A systematic review and meta-an	16
Standardization of the nomenclature of bone status indices: a milestone in diagnostic consistency and clarity	16

Comment on: Abdalbary et al. Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study.	16
Response to: “Zoledronate-induced acute anterior uveitis: a three-case report and brief review of literature”	16
Key insights into antiresorptive drug use and osteonecrosis in osteoporotic patients undergoing tooth extractions: A clinical and CBCT assessment	16
Race-specific FRAX models are evidence-based and support equitable care: a response to the ASBMR Task Force report on Clinical Algorithms for Fracture Risk	16
Letter of rebuttal to ‘Comment on: Imaging of pelvic ring fractures in older adults and its clinical implications—a systematic review’	16
The association of frailty with clinical and economic outcomes among hospitalized older adults with hip fracture surgery	16
Development and validation of a prediction model for falls among older people using community-based data	16
Author response to OSIN-D-24–00958 comment on: the association between myasthenia gravis and risk of fracture: a systematic review and meta-analysis	16
Risk factors for hip fracture	15
Bone mineral density and lipid profiles in older adults: a nationwide cross-sectional study	15
Correction to: Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study	15
Error in Mendelian randomization analysis in “Higher risk of osteoporosis in adult-onset asthma than childhood-onset asthma”	15
Correction to: Effect of institution volume on mortality and outcomes in osteoporotic hip fracture care	15
Bone, cognitive, and anthropometric profiles and their relation to fracture sites in fallers: a cross-sectional study	15
Comment on “Association of serum alkaline phosphatase levels with bone mineral density, osteoporosis prevalence, and mortality in US adults with osteoporosis: evidence from NHANES 2005–2018”	15
Correction: determination of the combined effects of asian herbal medicine with calcium and/or vitamin D supplements on bone mineral density in primary osteoporosis: a systematic review and meta-analy	15
Impact of the COVID-19 pandemic on osteoporotic hip fractures among outpatients in Germany	15
Author Response to OSIN-D-24–00437: Letter to the Editor regarding “Associations between ultra-distal forearm bone mineral density and incident fracture in women”	14
Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis	14
Osteoporotic vertebral fractures localized in the lumbar area significantly impact sagittal alignment	14
A longitudinal genome-wide association study of bone mineral density mean and variability in the UK Biobank	14
Mortality among older adults with osteoporotic vertebral fracture	14
A tribute to Uri A. Liberman, 1935–2022	14
Beneficial effects of denosumab on muscle performance in patients with low BMD: a retrospective, propensity score-matched study	14
Costs of incident non-hip osteoporosis-related fractures in postmenopausal women from a payer perspective	14
A novel fracture liaison service using digital health: impact on mortality in hospitalized elderly osteoporotic fracture patients	14
A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients	14
Fracture rates and economic outcomes in patients with osteoporosis prescribed risedronate gastro-resistant versus other oral bisphosphonates: a claims data analysis	14
Prevalence of low bone mineral density (T-score ≤  − 2.5) in the whole spectrum of chronic kidney disease: a systematic review and meta-analysis	14
Effects of non-supervised exercise interventions on bone mineral density in adult women: a systematic review and meta‑analysis	14
Prior fragility fractures are associated with a higher risk of 8-year complications following total shoulder arthroplasty	14
Rheumatoid arthritis and osteogenesis imperfecta: is there a genetic causal association?	14
Demographics and medical burden of osteogenesis imperfecta: a nationwide database analysis	13
Fragility fracture and fear of falling in middle aged adults-a prevalence study	13
The association between proton pump inhibitors and hyperparathyroidism: a potential mechanism for increased fracture—results of a large observational cohort study	13
Long-term clinical and socio-economic outcomes following wrist fracture: a systematic review and meta-analysis	13
Group-based trajectories of potentially preventable hospitalisations among older adults after a hip fracture	13
Effects of different exercise intensity on bone mineral density in adults: a comparative systematic review and meta-analysis	13
RE: Clinical features of fallers and non-fallers: Finding best-performing combinations of physical performance measurements to discriminate physical impairments between fallers and non-fallers among o	13
Birth weight and birth length affect future fracture risk differently in men and women	13
The high-risk hip fracture patient and the palliative care consult	13
Skeletal health status among patients with chronic hypoparathyroidism: results from the Canadian National Hypoparathyroidism Registry (CNHR)	13
Milk intake and hip fracture incidence in community-dwelling old Icelandic adults	13
The hip fracture incidence in the high-risk area Oslo continues to decline	13
Sex differences in recovery of quality of life 12 months post-fracture in community-dwelling older adults: analyses of the Australian arm of the International Costs and Utilities Related to Osteoporot	13
Delayed and significant hypercalcaemia due to teriparatide therapy: a case report and review	13
Comment on Byun et al.: The effect of teriparatide on fracture healing after atypical femoral fracture: a systematic review and meta-analysis	13
Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)	13
How can the orthopedic surgeon ensure optimal vitamin D status in patients operated for an osteoporotic fracture?	13
Metabolic factors associated with incident fracture among older adults with type 2 diabetes mellitus: a nested case–control study	13
Trabecular bone score in PODA, a Randomized Controlled Trial (RCT) in older African American Women	13
Prediabetes and insulin resistance are associated with lower trabecular bone score (TBS): cross-sectional results from the Study of Women’s Health Across the Nation TBS Study	13
Letter to the editor concerning “Sex differences in hemoglobin levels and five-year refracture risk in patients with osteoporotic fractures: a retrospective cohort analysis”	13
The effect of starting metformin on bone mineral density among women with type 2 diabetes in the Study of Women’s Health Across the Nation (SWAN)	12
Update on the role of bone turnover markers in the diagnosis and management of osteoporosis: a consensus paper from The European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthrit	12
Prognosis and institutionalization of frail community-dwelling older patients following a proximal femoral fracture: a multicenter retrospective cohort study	12
Focal dermal hypoplasia: a probable underrecognized low bone mass disorder secondary to aberrant Wnt signaling	12
Author response to: OSIN-D-24–00381, artificial intelligence insights into osteoporosis	12
Proposed diagnostic criteria for the diagnosis of hypophosphatasia in children and adolescents: results from the HPP International Working Group	12
Biochemical and clinical manifestations in adults with hypophosphatasia: a national cross-sectional study	12
MR-based proton density fat fraction (PDFF) of the vertebral bone marrow differentiates between patients with and without osteoporotic vertebral fractures	12
Osteoporosis in older patients with idiopathic normal pressure hydrocephalus	12
Health-related quality of life in osteoporosis: a systematic review of measurement properties of the QUALEFFO-41	12
Opportunistic use of lumbar computed tomography and magnetic resonance imaging for osteoporosis screening	12
Is teriparatide therapy effective for medication-related osteonecrosis of the jaw? A systematic review and meta-analysis	12
Lower limb bone geometry in adult individuals with X-linked hypophosphatemia: an observational study	12
Denosumab-associated symptomatic hypophosphatemia in normal kidney function: two case reports	12
Performance of FRAX in older adults with frailty: the Framingham Heart Study	11
Exploratory use of romosozumab for osteoporosis in a patient with Hajdu–Cheney syndrome: a case report	11
Effects of combined protein and exercise interventions on bone health in middle-aged and older adults — A systematic literature review and meta-analysis of randomized controlled trials	11
CT image-based biomarkers for opportunistic screening of osteoporotic fractures: a systematic review and meta-analysis	11
Physical function and physical activity in adults with X-linked hypophosphatemia	11
Improving the reporting of economic evaluation in osteoporosis: the value of CHEERS 2022 statement	11
Atypical periprosthetic femoral fracture with stem breakage: a case report	11
Changes in bone mineral density in Down syndrome individuals: a systematic review and meta-analysis	11
Incidence of hip fractures in Mexico 2006–2019: increasing numbers but decreasing rates	11
The diagnostic value of MRI-based vertebral bone quality score for osteoporosis or osteopenia in patients undergoing lumbar surgery: a meta-analysis	11
Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event	11
Opportunistic assessment of osteoporosis using hip and pelvic X-rays with OsteoSight™: validation of an AI-based tool in a US population	11
The Geriatrics at Risk Score (GeRi-Score) for mortality prediction in geriatric patients with proximal femur fracture – a development and validation study from the Registry for Geriatric Trauma (ATR-D	11

Discontinuation of denosumab in men with prostate cancer	11
Trends and regional variation in vertebroplasty and kyphoplasty in Switzerland: a population-based small area analysis	11
Thirty years of hip fracture incidence in Austria: is the worst over?	11
Effect of osteoporosis medications on vascular and valvular calcification: a systematic review and meta-analysis	11
B vitamins and bone health: a meta-analysis with trial sequential analysis of randomized controlled trials	11
Trabecular bone mineral density as measured by thoracic vertebrae predicts incident hip and vertebral fractures: the multi-ethnic study of atherosclerosis	11
Patients’ preferences for fracture risk communication: the Risk Communication in Osteoporosis (RICO) study	11
The Capture the Fracture® Partnership: an overview of a global initiative to increase the secondary fracture prevention care for patient benefit	11
Standardized 25(OH)D and fall risk: overcoming challenges and enhancing clinical applications	10
Predictive performance of the Garvan Fracture Risk Calculator: a registry-based cohort study	10
Bone density and fracture risk factors in ankylosing spondylitis: a meta-analysis	10
Vertebral fracture severity assessment on anteroposterior radiographs with a new semi-quantitative technique	10
Cost-effectiveness intervention thresholds for romosozumab and teriparatide in the treatment of osteoporosis in the UK	10
Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture	10
Examining effects of habitual physical activity and body composition on bone structure in early post-menopausal women: a pQCT analysis	10
Impact of switching from bisphosphonates to denosumab, teriparatide, or romosozumab in patients with postmenopausal osteoporosis: a case–control study	10
Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis	10
An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures	10
Trends in screening and treatment of osteoporosis after periprosthetic fractures from 2010 to 2020	10
Magnesium exposure increases hip fracture risks in patients with chronic kidney disease: a population-based nested case–control study	10
Appropriate dosing of burosumab in tumor-induced osteomalacia	10
The pattern of incident fractures according to fracture site in people with T1D	10
Effect of postural alignment alteration with age on vertebral strength	10
Reply to comments on “Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis”	10
Bridging the gap: enhancing osteoporosis management through AI-driven predictive models	10
Is it important to achieve physical activity recommendations at early stages of life to improve bone health?	10
Association between total and animal proteins with risk of fracture: A systematic review and dose–response meta-analysis of cohort studies	9
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): Plenary Lecture Abstracts	9
Gender differences in osteoporosis	9
Association of atypical femoral fracture location and lower limb mechanical axis: a computed tomography-based finite element analysis	9
Development of a novel method to measure bone marrow fat fraction in older women using high-resolution peripheral quantitative computed tomography	9
Commentary on the Broader Perspectives of Hip Fractures in Primary Aldosteronism: From Medical to Social	9
Efficacy and safety of candidate biosimilar CT-P41 versus reference denosumab: a double-blind, randomized, active-controlled, Phase 3 trial in postmenopausal women with osteoporosis	9
The imminent risk of a fracture—existing worldwide data: a systematic review and meta-analysis	9
Effect of yoga on balance, falls, and bone metabolism: a systematic review of randomized controlled trials in healthy individuals	9
Transient osteoporosis of the hip following discontinuation of denosumab and switch to alendronate treatment	9
Fragility fracture patients with a history of prior fractures more likely to present with multiple risk factors: findings from a province-wide fracture liaison service	9
RE: Advanced 2D image processing technique to predict hip fracture risk in an older population based on single DXA scans	9
Determining the pharmacologic window of bisphosphonates that mitigates severe injury-induced osteoporosis and muscle calcification, while preserving fracture repair	9
Patients with periprosthetic femoral fractures are older adults who are commonly diagnosed with osteoporosis	9
Management of osteoporosis in patients with chronic kidney disease	9
Establishing a Chinese older hip fracture registry for older patients: a Delphi study to define the focus and key variables for this registry	9
Correction: Risk of major osteoporotic fractures among ultra-orthodox Jews	9
Publisher Correction to: Development of the Asia Pacific Consortium on Osteoporosis (APCO) framework: clinical standards of care for the screening, diagnosis, and management of osteoporosis in the Asi	9
Longitudinal assessment of physical function in adults with X-linked hypophosphatemia following initiation of burosumab therapy	9
Addressing the global burden of vitamin D deficiency: insights, challenges, and the need for personalized supplementation	9
FREM predicts 10-year incident fracture risk independent of FRAX® probability: a registry-based cohort study	9
Cost-effectiveness of FRAX®-based intervention thresholds for management of osteoporosis in Indian women: a Markov microsimulation model analysis	9
The effect of hypersensitive C-reactive protein to albumin ratio on the risk of fragility fracture in the Chinese male population	9
Systematic review and meta-analysis of preoperative predictors for early mortality following hip fracture surgery	9
One- and 2-year incidence of osteoporotic fracture: a multi-cohort observational study using routinely collected real-world data	9
FRAX-based intervention thresholds for Pakistan	9
Association between outdoor particulate air pollution and the risk of osteoporosis: a systematic review and meta-analysis	9
Treatment of glucocorticoid-induced osteoporosis with concurrent denosumab and romosozumab: a case report	9
Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report	9
DXA-based bone strain index in normocalcemic primary hyperparathyroidism	9
IOF REGIONAL 2021 8th Asia Pacific Osteoporosis Conference : Poster Abstracts	9
IOF position on scientists and societies operating in conflict zones	9
Correction to: Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up	9
Primary hyperphosphatemic tumoral calcinosis: a case report	8
The significance of recent fracture location for imminent risk of hip and vertebral fractures—a nationwide cohort study on older adults in Sweden	8
The clinician’s guide to prevention and treatment of osteoporosis	8
Trends in hip fracture rates in US male veterans	8
Denosumab-related osteonecrosis of the jaw after tooth extraction and the effects of a short drug holiday in cancer patients: a multicenter retrospective study	8
Long-term effects of lifestyle and metformin interventions in DPP on bone density	8
Protein intake and bone health: an umbrella review of systematic reviews for the evidence-based guideline of the German Nutrition Society	8
Selection for treatment of patients at high risk of fracture by the short versus long term prediction models — data from the Belgian FRISBEE cohort	8
A cost-consequence analysis of a community-based rehabilitation programme following hip fracture (Fracture in the Elderly Multidisciplinary Rehabilitation—FEMuR III)	8
Promising diagnostic performance of CBCT-based TOMOSTEOp algorithm in osteoporosis: toward a complementary populational screening tool managed by dentists?	8
Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017–2018	8
Treatment patterns and long-term persistence with osteoporosis therapies in women with Medicare fee-for-service (FFS) coverage	8
Osteoporosis and the long-term risk of peripheral artery disease: a population-based longitudinal follow-up study in Taiwan	8
Adjusting conventional FRAX estimates of fracture probability according to the number of prior fractures	8
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): SICOT-ESCEO-IOF Symposium Abstracts	8
Time trend analysis of osteoporosis prevalence among adults 50 years of age and older in the USA, 2005–2018	8
Long-term effect of denosumab on bone microarchitecture as assessed by tissue thickness–adjusted trabecular bone score in postmenopausal women with osteoporosis: results from FREEDOM and its open-labe	8
Diagnostic performance of radiomics for predicting osteoporosis in adults: a systematic review and meta-analysis	8
Differences in femoral fracture localizations in men and women in Switzerland between 1998 and 2021—reversal of the secular trend?	8
Heel quantitative ultrasound (QUS) predicts incident fractures independently of trabecular bone score (TBS), bone mineral density (BMD), and FRAX: the OsteoLaus Study	8
Comments on “Relatively low and moderate pre-fracture serum 25-hydroxyvitamin D levels associated with the highest survival in elderly hip fracture patients in Finland: a minimum 3-year follow-up”	8
No association of anti-osteoporosis drugs with COVID-19-related outcomes in women: a nationwide cohort study	8
Correction to: Artificial intelligence-enhanced opportunistic screening of osteoporosis in CT scan: a scoping Review	8
Pubertal increment in insulin resistance is negatively related to lumbar bone mineral density in 18-year-old males	8
Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX	8
Pharmacist interventions in osteoporosis management: a systematic review	8
Comment on: A multicenter retrospective study of the risk factors associated with medication-related osteonecrosis of the jaw after tooth extraction in patients receiving oral bisphosphonate therapy:	8
Liver enzyme inducing anticonvulsant drug use is associated with prevalent vertebral fracture	8
Evidence-based joint statement position of perioperative bone optimization in the arthroplasty candidate, from FEMECOT, AMMOM, ACOMM, SCCOT, SECOT, SEFRAOS, SEIOMM	8
The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review	8
Weight change and the risk of hip fractures in patients with type 2 diabetes: a nationwide cohort study	8